Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study

@article{Tai2017CilostazolUI,
  title={Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study},
  author={Shu-Yu Tai and Chen-Yu Chien and Yu-Han Chang and Yuan-Han Yang},
  journal={Neurotherapeutics},
  year={2017},
  volume={14},
  pages={784-791}
}
  • Shu-Yu Tai, Chen-Yu Chien, +1 author Yuan-Han Yang
  • Published in Neurotherapeutics 2017
  • Medicine
  • Whether antiplatelet agents have a preventive effect on cognitive function remains unknown. We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population. Patients initiating cilostazol therapy between 1 January 2004 and 31 December 2009 without a prior history of dementia were identified from Taiwan's National Health Insurance database. Participants… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    5
    Twitter Mentions

    Citations

    Publications citing this paper.
    SHOWING 1-7 OF 7 CITATIONS

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 29 REFERENCES

    Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.

    • Wen Wang, Lu Lu Zhang, +3 authors Jizong Zhao
    • Medicine
    • Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
    • 2016

    Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis.

    VIEW 1 EXCERPT

    Model

    • K Tanaka, F Gotoh, +3 authors J Kawamura
    • 2012